Werewolf Therapeutics Inc stock is traded at $1.01, with a volume of 176,559. It is down -0.98% in the last 24 hours and up +9.76% over the past month. Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
Previous Close:
$1.02
Open:
$1.02
24h Volume:
176,559
Relative Volume:
0.54
Market Cap:
$49.09M
Revenue:
$1.14M
Net Income/Loss:
-$56.27M
P/E Ratio:
-
EPS:
-$1.21
Net Cash Flow:
-$51.94M
1W Performance:
+2.42%
1M Performance:
+9.76%
6M Performance:
+55.34%
1Y Performance:
-15.83%
1-Day Range:
$0.9826$1.03
1-Week Range:
$0.9826$1.10
52-Week Range:
$0.27$1.27
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
617-952-0555Address
200 TALCOTT AVENUE, WATERTOWN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS